Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated circulating leukemia inhibitory factor in patients with extensive burns.

Sadanori Akita1, Kozo Akino, Song Guang Ren

  • 1Division of Plastic and Reconstructive Surgery, Department of Developmental and Reconstructive Medicine Nagasaki University, Graduate School of Biomedical and Sciences, Nagasaki, Japan.

Journal of Burn Care & Research : Official Publication of the American Burn Association
|March 29, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Efficacy and Broad-Spectrum Antimicrobial Activity of pH-Controlled Sodium Hypochlorite Solution (HACCP'ER) in Acute and Chronic Wound Management: A Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Cancer Risk in Acromegaly: Reassessing the Evidence and Impact of Biochemical Control.

The Journal of clinical endocrinology and metabolism·2026
Same author

Impact of acromegaly subtypes on survival: results from a large multicenter cohort.

Journal of the Endocrine Society·2026
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.

Journal of plastic and reconstructive surgery·2026
Same author

Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022.

Surgery today·2026

Leukemia inhibitory factor (LIF) and hypothalamic-pituitary-adrenal (HPA) axis markers indicate disease severity in major burn patients. Elevated LIF and HPA axis activity correlate with poorer prognosis and increased mortality in extensive burn cases.

Area of Science:

  • Burn injury research
  • Endocrinology
  • Immunology

Background:

  • Major burns trigger a significant systemic stress response.
  • The hypothalamic-pituitary-adrenal (HPA) axis is a key component of this stress response.
  • Leukemia inhibitory factor (LIF) is implicated as a mediator of HPA axis activity.

Purpose of the Study:

  • To investigate circulating cytokine responsiveness, specifically LIF, in major burn patients.
  • To assess the association between LIF levels and HPA axis markers.
  • To determine the prognostic value of LIF and HPA axis markers in extensive burns.

Main Methods:

  • Studied 20 extensively burned patients (burn surface area >20%).
  • Measured circulating LIF, adrenocorticotropic hormone (ACTH), and 24-hour urinary free cortisol.

Related Experiment Videos

  • Analyzed inflammatory markers and correlated LIF with HPA axis activity.

    • Main Results:

    • Significantly higher LIF, ACTH, and urinary free cortisol levels were observed in patients who died compared to survivors.
    • Elevated LIF levels at 36 hours post-injury correlated with mortality.
    • Significant correlations were found between serum LIF and both urinary free cortisol and plasma ACTH.

    Conclusions:

    • Serum LIF and HPA axis activity markers are valuable indicators of disease severity in extensive burn patients.
    • These markers can aid in predicting prognosis for individuals with severe burn injuries.
    • LIF may play a crucial role in the HPA axis response to major trauma.